Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P F Redfern

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanomaDavid S Hill, Shaun Martin, Jane L Armstrong, et al.
Cancer Research|July 3, 2008
Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stressPenny E Lovat, Marco Corazzari, Jane L Armstrong, et al.
The Journal of Investigative Dermatology|June 4, 2010
Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapyEmma L Hiscutt, David S Hill, Shaun Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Low prevalence of the N363S polymorphism of the glucocorticoid receptor in South Asians living in the United KingdomAkheel A Syed, Julie A E Irving, Christopher P F Redfern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2011
Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibitionJane L Armstrong, Marco Corazzari, Shaun Martin, et al.
Organic & Biomolecular Chemistry|December 17, 2008
Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiationVictoria B Christie, Jonathan H Barnard, Andrei S Batsanov, et al.
Cancer Research|September 18, 2002
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastomaPenny E Lovat, Serafina Oliverio, Marco Ranalli, et al.
The Journal of Investigative Dermatology|February 13, 2015
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell deathJane L Armstrong, David S Hill, Christopher S McKee, et al.
Journal of Gastroenterology|September 4, 2021
Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutationTakahiko Toyonaga, Taku Kobayashi, Satoshi Kuronuma, et al.
Bioorganic & Medicinal Chemistry|September 20, 2012
Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoatesMohamed S Gomaa, Andrew S T Lim, S C Wilson Lau, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanomaDavid S Hill, Shaun Martin, Jane L Armstrong, et al.
Cancer Research|July 3, 2008
Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stressPenny E Lovat, Marco Corazzari, Jane L Armstrong, et al.
The Journal of Investigative Dermatology|June 4, 2010
Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapyEmma L Hiscutt, David S Hill, Shaun Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Low prevalence of the N363S polymorphism of the glucocorticoid receptor in South Asians living in the United KingdomAkheel A Syed, Julie A E Irving, Christopher P F Redfern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2011
Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibitionJane L Armstrong, Marco Corazzari, Shaun Martin, et al.
Organic & Biomolecular Chemistry|December 17, 2008
Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiationVictoria B Christie, Jonathan H Barnard, Andrei S Batsanov, et al.
Cancer Research|September 18, 2002
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastomaPenny E Lovat, Serafina Oliverio, Marco Ranalli, et al.
The Journal of Investigative Dermatology|February 13, 2015
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell deathJane L Armstrong, David S Hill, Christopher S McKee, et al.
Journal of Gastroenterology|September 4, 2021
Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutationTakahiko Toyonaga, Taku Kobayashi, Satoshi Kuronuma, et al.
Bioorganic & Medicinal Chemistry|September 20, 2012
Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoatesMohamed S Gomaa, Andrew S T Lim, S C Wilson Lau, et al.
Pageof 6